4//SEC Filing
Moran Kyle 4
Accession 0000950170-24-114422
CIK 0001631574other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 8:00 PM ET
Size
6.9 KB
Accession
0000950170-24-114422
Insider Transaction Report
Form 4
Moran Kyle
Chief Financial Officer
Transactions
- Exercise/Conversion
Share Option (right to buy)
2024-10-11−25,000→ 0 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (25,000 underlying) - Exercise/Conversion
Ordinary Shares
2024-10-11$2.48/sh+25,000$62,000→ 44,777 total
Footnotes (1)
- [F1]The share options that were exercised via cash purchase in this reportable transaction were fully vested.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657765
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 8:00 PM ET
- Size
- 6.9 KB